Advertisement Stereotaxis receives approval for magnetic irrigated catheter - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Stereotaxis receives approval for magnetic irrigated catheter

Stereotaxis has received FDA's approval for its partnered magnetic irrigated catheter for use in mapping and ablation in the US.

Bevil Hogg, CEO of Stereotaxis, said: “The Stereotaxis Magnetic Navigation System, used in conjunction with the magnetic irrigated catheter and the company’s latest software release has performed extremely well with a high degree of safety. We are confident that the Stereotaxis Magnetic Navigation System with the irrigated catheter has the potential to establish a new standard of care in the treatment of complex arrhythmias.”